Product Information
FLUOXETINE DR 90 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $30.6818 per EA under NDC 55111028448. Its NADAC has been published 601 times since Nov 28, 2013.
FDA first approved this application on Mar 22, 2010.
The High Outlier badge above means this manufacturer's average price in the Fluoxetine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
90 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111028448
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078572FDA Approved
3/22/2010
On Market Since
3/24/2010
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE DR 90 MG CAPSULE has been published 601 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $30.6818 per EA |
|---|---|
| All-time high | $37.0486 (Jul 15, 2015) |
| All-time low | $25.6334 (Jul 17, 2024) |
| 52-week high | $30.7277 |
| 52-week low | $30.1283 |
| Median price | $29.9985 |
| Average price | $30.4059 |
| Largest weekly change | +13.0% (Mar 20, 2024) |
| Weeks tracked | 601 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fluoxetine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluoxetine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOXETINE DR 90 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE DR 90 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $30.6818 per EA (NDC 55111028448), effective Sep 30, 2026.
How has the price of FLUOXETINE DR 90 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUOXETINE DR 90 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 601 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLUOXETINE DR 90 MG CAPSULE?
Since Nov 28, 2013, the NADAC for FLUOXETINE DR 90 MG CAPSULE has ranged from a low of $25.6334 (Jul 17, 2024) to a high of $37.0486 (Jul 15, 2015), with a median of $29.9985 per EA.
Are there cheaper alternatives to FLUOXETINE DR 90 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of FLUOXETINE DR 90 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUOXETINE DR 90 MG CAPSULE?
FLUOXETINE DR 90 MG CAPSULE (NDC 55111028448) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.